Getinge
ISIN: SE0000202624 | Ticker: GETI | LEI: 5493003PZ4F570G3W735
Country: Sweden
Around the world, there are many health care challenges to solve. The population is growing and people are getting older, while more illnesses are on the rise. Traditional infections, together with welfare diseases such as cardiovascular diseases, obesity and diabetes, are putting huge pressure on health care. More people will need treatments, but there are fewer resources at hand.
At Getinge, we are committed to meet those challenges together with health care providers and be part of improving patients’ lives around the globe. Our offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science.
Our journey started in the village of Getinge on the Swedish west coast back in 1904. Today, our operations cover more than 40 countries and we over 10 000 employees. Every single one of us with the firm belief that saving lives is the best job in the world.
1904
Served areaWorldwide
Headcount10,700
HeadquartersLindholmspiren 7A, 41756 Göteborg – Sweden
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 45,014,000,000.00 | 44,555,000,000.00 | 52,032,000,000.00 |
| Noncurrent Assets | N/A | 27,584,000,000.00 | 29,486,000,000.00 | 32,926,000,000.00 |
| Property Plant And Equipment | N/A | 2,956,000,000.00 | 3,060,000,000.00 | 3,532,000,000.00 |
| Deferred Tax Assets | N/A | 1,474,000,000.00 | 1,166,000,000.00 | 998,000,000.00 |
| Other Noncurrent Financial Assets | N/A | 50,000,000.00 | 52,000,000.00 | 50,000,000.00 |
| Noncurrent Derivative Financial Assets | N/A | 2,000,000.00 | 0.00 | 0.00 |
| Current Assets | N/A | 17,431,000,000.00 | 15,069,000,000.00 | 19,106,000,000.00 |
| Inventories | N/A | 4,513,000,000.00 | 4,767,000,000.00 | 6,232,000,000.00 |
| Current Trade Receivables | N/A | 5,338,000,000.00 | 4,695,000,000.00 | 5,275,000,000.00 |
| Current Prepayments And Current Accrued Income Other Than Current Contract Assets | N/A | N/A | 283,000,000.00 | 423,000,000.00 |
| Other Current Receivables | N/A | 752,000,000.00 | 732,000,000.00 | 697,000,000.00 |
| Current Tax Assets Current | N/A | 63,000,000.00 | 66,000,000.00 | 52,000,000.00 |
| Cash and cash equivalents | 1,254,000,000.00 | 6,056,000,000.00 | 4,076,000,000.00 | 5,676,000,000.00 |
| Current Derivative Financial Assets | N/A | 23,000,000.00 | 2,000,000.00 | 71,000,000.00 |
| Equity And Liabilities | N/A | 45,014,000,000.00 | 44,555,000,000.00 | 52,032,000,000.00 |
| Equity | 20,973,000,000.00 | 21,486,000,000.00 | 25,176,000,000.00 | 30,453,000,000.00 |
| Issued Capital | N/A | 136,000,000.00 | 136,000,000.00 | 136,000,000.00 |
| Retained Earnings | N/A | 14,422,000,000.00 | 16,579,000,000.00 | 18,796,000,000.00 |
| Share Premium | N/A | 6,789,000,000.00 | 6,789,000,000.00 | N/A |
| Other Reserves | N/A | -323,000,000.00 | 1,245,000,000.00 | 4,317,000,000.00 |
| Additional Paidin Capital | N/A | N/A | 6,789,000,000.00 | 6,789,000,000.00 |
| Equity Attributable To Owners Of Parent | N/A | 21,024,000,000.00 | 24,750,000,000.00 | 30,038,000,000.00 |
| Noncontrolling Interests | N/A | 462,000,000.00 | 427,000,000.00 | 415,000,000.00 |
| Noncurrent Liabilities | N/A | 13,740,000,000.00 | 8,769,000,000.00 | 9,585,000,000.00 |
| Other Longterm Provisions | N/A | 1,362,000,000.00 | 681,000,000.00 | 655,000,000.00 |
| Deferred Tax Liabilities | N/A | 829,000,000.00 | 897,000,000.00 | 1,150,000,000.00 |
| Noncurrent Derivative Financial Liabilities | N/A | 14,000,000.00 | 1,000,000.00 | 0.00 |
| Other Noncurrent Liabilities | N/A | 294,000,000.00 | 124,000,000.00 | 132,000,000.00 |
| Longterm Borrowings | N/A | 7,020,000,000.00 | 2,795,000,000.00 | 4,100,000,000.00 |
| Current Liabilities | N/A | 9,788,000,000.00 | 10,610,000,000.00 | 11,993,000,000.00 |
| Other Shortterm Provisions | N/A | 519,000,000.00 | 2,331,000,000.00 | 2,932,000,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 1,446,000,000.00 | 1,921,000,000.00 | 2,252,000,000.00 |
| Current Contract Liabilities | N/A | 1,355,000,000.00 | 1,633,000,000.00 | 2,336,000,000.00 |
| Current Tax Liabilities Current | N/A | 376,000,000.00 | 533,000,000.00 | 442,000,000.00 |
| Current Derivative Financial Liabilities | N/A | 0.00 | 27,000,000.00 | 137,000,000.00 |
| Other Current Liabilities | N/A | 495,000,000.00 | 476,000,000.00 | 380,000,000.00 |
| Line item in (sek) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 29,819,000,000.00 | 27,049,000,000.00 | 28,292,000,000.00 |
| Other Income | 1,026,000,000.00 | 720,000,000.00 | 642,000,000.00 |
| Profit Loss From Operating Activities | 4,784,000,000.00 | 4,371,000,000.00 | 3,626,000,000.00 |
| Finance Income | 8,000,000.00 | 10,000,000.00 | 141,000,000.00 |
| Finance Costs | 307,000,000.00 | 193,000,000.00 | 295,000,000.00 |
| Profit Loss Before Tax | 4,485,000,000.00 | 4,188,000,000.00 | 3,472,000,000.00 |
| Income Tax Expense Continuing Operations | 1,213,000,000.00 | 1,187,000,000.00 | 956,000,000.00 |
| Profit (loss) | 3,273,000,000.00 | 3,000,000,000.00 | 2,516,000,000.00 |
| Profit Loss Attributable To Owners Of Parent | 3,239,000,000.00 | 2,970,000,000.00 | 2,491,000,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 34,000,000.00 | 31,000,000.00 | 25,000,000.00 |
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | 3,273,000,000.00 | 3,000,000,000.00 | 2,516,000,000.00 |
| Adjustments For Decrease Increase In Inventories | N/A | -544,000,000.00 | -71,000,000.00 | -998,000,000.00 |
| Adjustments For Provisions | N/A | 169,000,000.00 | 61,000,000.00 | 205,000,000.00 |
| Other Adjustments For Noncash Items | N/A | 60,000,000.00 | 460,000,000.00 | 11,000,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | 553,000,000.00 | 693,000,000.00 | 1,012,000,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 7,199,000,000.00 | 6,560,000,000.00 | 3,367,000,000.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 999,000,000.00 | 715,000,000.00 | 365,000,000.00 |
| Proceeds From Other Longterm Assets Classified As Investing Activities | N/A | 53,000,000.00 | 316,000,000.00 | 31,000,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -1,991,000,000.00 | -1,329,000,000.00 | -1,470,000,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 4,327,000,000.00 | 1,170,000,000.00 | 1,462,000,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 3,784,000,000.00 | 7,159,000,000.00 | 441,000,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 390,000,000.00 | 389,000,000.00 | 415,000,000.00 |
| Dividends Paid Classified As Financing Activities | N/A | 433,000,000.00 | 858,000,000.00 | 1,111,000,000.00 |
| Other Inflows Outflows Of Cash Classified As Financing Activities | N/A | -17,000,000.00 | -1,000,000.00 | 5,000,000.00 |
| Cash Flows From Used In Financing Activities | N/A | -297,000,000.00 | -7,237,000,000.00 | -500,000,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 4,911,000,000.00 | -2,006,000,000.00 | 1,397,000,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -110,000,000.00 | 26,000,000.00 | 203,000,000.00 |
| Cash and cash equivalents | 1,254,000,000.00 | 6,056,000,000.00 | 4,076,000,000.00 | 5,676,000,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 16.06.22 | Eva Christina Malin Persson | Other | Buy | SEK 527,500.00 |
| 16.05.22 | Eric Honroth | Other | Buy | USD 4,350.00 |
| 03.05.22 | Johan Bygge | Other | Buy | SEK 986,000.00 |
| 03.05.22 | Stephane Le Roy | Other | Buy | SEK 289,300.00 |
| 03.05.22 | Stephane Le Roy | Other | Buy | SEK 88,290.00 |
| 02.05.22 | MATTIAS PERJOS | Other | Buy | SEK 4,187,250.00 |
| 02.05.22 | Elin Frostehav | Other | Buy | SEK 89,974.80 |
| 02.05.22 | Elin Frostehav | Other | Buy | SEK 58,317.00 |
| 02.05.22 | Elin Frostehav | Other | Buy | SEK 30,269.30 |
| 02.05.22 | Elin Frostehav | Other | Buy | SEK 24,151.20 |
| Position Holder | Short Interest in Percent | Date |
|---|---|---|
| Qube Research & Technologies Limited | 0.57% | 27.02.24 |
| Qube Research & Technologies Limited | 0.60% | 20.02.24 |
| Total | 1.17% |
SE0000202624
LEI5493003PZ4F570G3W735
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryOMX Stockholm 30
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.